2023
Wikoff D , Ring C, DeVito M, Walker N, Birnbaum L, Haws L. 2023. Development and application of a systematic and quantitative weighting framework to evaluate the quality and relevance of relative potency estimates for dioxin-like compounds (DLCs) for human health risk assessment. Regul Toxicol Pharmacol 145:105500; doi: 10.1016/j.yrtph.2023.105500 . PMID: 37866700.
View Abstract
Publication: Manuscripts
/ Topics: dioxin , Epidemiology , risk assessment
Perry CS , Blanchette AD, Vivanco SN, Verwiel AH, Proctor DM. 2023. Use of physiologically based pharmacokinetic modeling to support development of an acute (24-hour) health-based inhalation guideline for manganese. Regul Toxicol Pharmacol 145:105518; doi: 10.1016/j.yrtph.2023.105518 . PMID: 3786341.
View Abstract
Publication: Manuscripts
/ Topics: Air Quality , Epidemiology , Manganese , modeling , pharmacokinetics
Thompson CM , Kirman C, Harris MA. 2023. Derivation of oral cancer slope factors for hexavalent chromium informed by pharmacokinetic models and in vivo genotoxicity data. Regul Toxicol Pharmacol 145(Dec):105521; doi: 10.1016/j.yrtph.2023.105521 . PMID: 37863416.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , chromium , genotoxicity , modeling , pharmacokinetics
Heintz M , Thompson C , Fitch S , Rogers S, Wikoff D , Haws L, Rivera B. 2023. Protocol to develop updated oral toxicity values for HFPO-DA. OSF | Protocol_Oct2023.pdf .
Publication: Protocol Registrations
/ Topics: ammonium , Metals
Henderson RG , Vincent M, Rivera BN, Bonn-Miller MO, Doepker C. 2023. Cannabidiol safety considerations: Development of a potential acceptable daily intake value and recommended upper intake limits for dietary supplement use. Regul Toxicol Pharmacol 144(Oct):105482; doi: 10.1016/j.yrtph.2023.105482 . PMID: 37634699.
View Abstract
Publication: Manuscripts
/ Topics: Cannabinoid/Industrial Hemp
Kulpa J, Lefever TW, Trexler KR, Henderson RG , MacNair L, Toth ML, Vanapalli SA, Rahman M, Gupta S, Bonn-Miller MO. 2023. Toxicity of cannabigerol: Examination of long-term toxicity and lifespan in Caenorhabditis elegans and 14-day study in Sprague Dawley rats. Cannabis Cannabinoid Res 8(S1):S62–S70; doi: 10.1089/can.2023.0035 .
View Abstract
Publication: Manuscripts
/ Topics: Cannabinoid/Industrial Hemp
Kulpa J, Henderson RG , Schwotzer D, Dye W, Trexler KR, McDonald J, Lefever TW, Bonn-Miller MO. 2023. Toxicological evaluation and pain assessment of four minor cannabinoids following 14-day oral administration in rats. Cannabis Cannabinoid Res 8(S1):S25–S41 doi: 10.1089/can.2023.0049 . PMID: 37721989.
View Abstract
Publication: Manuscripts
/ Topics: Cannabinoid/Industrial Hemp
Wharton GT, Becker C, Bennett D, Burcu M, Bushnell G, …, Movva N, …, Suh M , et al. Overview of global real world data sources for pediatric pharmacoepidemiological research. Poster 217, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology
Bowden A, Escher S, Rose J, Sadekar N, Patlewicz G , O’Keeffe L, Bury D, Hewitt NJ, et al. 2023. Workshop report: Challenges faced in developing inhalation thresholds of Toxicological Concern (TTC) – State of the science and next steps. Regul Toxicol Pharmacol 142(Aug):105434; doi: 10.1016/j.yrtph.2023.105434 . PMID: 37302561.
View Abstract
Publication: Manuscripts
/ Topics: risk assessment
Pastula S, Suh M , Jiang X, Reichert H, Movva N, Fryzek J, Simões EAF. Respiratory syncytial virus (RSV) and bronchiolitis epidemiology among the United States infant Medicaid populations in seven states. Poster 191, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract